Literature DB >> 6281119

A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.

I Miyoshi, I Kubonishi, S Yoshimoto, Y Shiraishi.   

Abstract

A unique T-cell line, MT-2, was established from normal human cord leukocytes of a male infant by co-culturing with leukemic T-cells from a female patient with adult T-cell leukemia. MT-2 cells expressed receptors for sheep erythrocytes and complement and were reactive with anti-T-cell and anti-Ia sera. They were negative for Fc receptors, surface immunoglobulin, and Epstein-Barr virus nuclear antigen. Chromosomally, the MT-2 line was male and most cells were shown to have a normal diploid karyotype. The cultured cells were tumorigenic when transplanted into immunosuppressed newborn hamsters.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6281119

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  52 in total

1.  A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.

Authors:  Y Saitoh; A Hamano; K Mochida; A Kakeya; M Uno; E Tsuruyama; H Ichikawa; F Tokunaga; A Utsunomiya; T Watanabe; S Yamaoka
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528

2.  Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy.

Authors:  Y Ohara; Y Iwasaki; S Izumo; I Kobayashi; A Yoshioka
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Authors:  Y Takahashi; Y Tanaka; A Yamashita; Y Koyanagi; M Nakamura; N Yamamoto
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line.

Authors:  Morgan E Meissner; Luiza M Mendonça; Wei Zhang; Louis M Mansky
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

5.  Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Authors:  Blanca E Ruiz-Medina; Jeremy A Ross; Robert A Kirken
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

6.  Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.

Authors:  Laura J Martins; Pawel Bonczkowski; Adam M Spivak; Ward De Spiegelaere; Camille L Novis; Ana Beatriz DePaula-Silva; Eva Malatinkova; Wim Trypsteen; Alberto Bosque; Linos Vanderkerckhove; Vicente Planelles
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-14       Impact factor: 2.205

7.  Infection of defective human T-lymphotropic virus type 1.

Authors:  Yuuki Hashikura; Kazumi Umeki; Kunihiko Umekita; Hajime Nomura; Akiteru Yamada; Ikuo Yamamoto; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama
Journal:  Hum Cell       Date:  2017-01-09       Impact factor: 4.174

8.  Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.

Authors:  H Hata; H Matsuzaki; F Matsuno; T Sonoki; S Takemoto; N Kuribayashi; A Nagasaki; K Takatsuki
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Authors:  Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.

Authors:  Zsuzsanna S Nagy; Matthew J LeBaron; Jeremy A Ross; Abhisek Mitra; Hallgeir Rui; Robert A Kirken
Journal:  Mol Cancer       Date:  2009-08-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.